Sign in

CIK 0001816736

  • Large accelerated filer

Disc Medicine, Inc.

Sign in to watch
Ticker
IRON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
851612845
Phone
+1 617-674-9274
Business address
321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
Former names
Gemini Therapeutics, Inc. /DE, FS Development Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,877,065
in 6 filings, $10.0M under 10b5-1 plans

Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 32 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-23 Atlas Venture Fund X, L.P. 10% owner Sale −82,500 $67.65 $5.6M 703,660
2024-01-23 Atlas Venture Fund X, L.P. 10% owner Sale −20,000 $67.65 $1.4M 198,326
2024-01-10 Bryce Joanne Chief Financial Officer Grant or award +18,165 23,665
2024-01-10 Bryce Joanne Chief Financial Officer Grant or award · Stock Option (Right to Buy) +27,250 27,250
2024-01-10 Quisel John D Chief Executive Officer Grant or award +66,365 69,065
2024-01-10 Quisel John D Chief Executive Officer Grant or award · Stock Option (Right to Buy) +99,550 99,550
2024-01-10 Khara Rahul General Counsel Grant or award +14,035 14,035
2024-01-10 Khara Rahul General Counsel Grant or award · Stock Option (Right to Buy) +21,050 21,050
2024-01-10 Yu Jonathan Yen-Wen Chief Business Officer Grant or award +18,165 18,165
2024-01-10 Yu Jonathan Yen-Wen Chief Business Officer Grant or award · Stock Option (Right to Buy) +27,250 27,250
2024-01-10 Savage William Jacob Chief Medical Officer Grant or award +18,535 21,535
2024-01-10 Savage William Jacob Chief Medical Officer Grant or award · Stock Option (Right to Buy) +27,800 27,800
2024-01-10 Bitterman Kevin Director Sale −20,000 $64.00 $1.3M 786,160
2024-01-10 Atlas Venture Fund X, L.P. 10% owner Sale −30,000 $64.00 $1.9M 1,449,686
2024-01-10 Atlas Venture Fund X, L.P. 10% owner Sale −20,000 $64.00 $1.3M 786,160
2023-12-29 Quisel John D Chief Executive Officer Option exercise +2,700 $1.01 $3K 2,700
2023-12-29 Quisel John D Chief Executive Officer Option exercise · Stock Option (Right to Buy) −2,700 241,211
2023-12-27 Bryce Joanne Chief Financial Officer Option exercise +3,000 $9.86 $30K 5,500
2023-12-27 Bryce Joanne Chief Financial Officer Option exercise · Stock Option (Right to Buy) −3,000 73,745
2023-12-18 ORBIMED ADVISORS LLC Director Option exercise +1,724 $38.00 $66K 1,724

Page 23 of 32 · 639 trades